LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 193

Search options

  1. Article: Oxidative Damage and Telomere Length as Markers of Lung Cancer Development among Chronic Obstructive Pulmonary Disease (COPD) Smokers.

    Córdoba-Lanús, Elizabeth / Montuenga, Luis M / Domínguez-de-Barros, Angélica / Oliva, Alexis / Mayato, Delia / Remírez-Sanz, Ana / Gonzalvo, Francisca / Celli, Bartolomé / Zulueta, Javier J / Casanova, Ciro

    Antioxidants (Basel, Switzerland)

    2024  Volume 13, Issue 2

    Abstract: Lung cancer (LC) constitutes an important cause of death among patients with Chronic Obstructive Pulmonary Disease (COPD). Both diseases may share pathobiological mechanisms related to oxidative damage and cellular senescence. In this study, the ... ...

    Abstract Lung cancer (LC) constitutes an important cause of death among patients with Chronic Obstructive Pulmonary Disease (COPD). Both diseases may share pathobiological mechanisms related to oxidative damage and cellular senescence. In this study, the potential value of leucocyte telomere length, a hallmark of aging, and 8-OHdG concentrations, indicative of oxidative DNA damage, as risk biomarkers of LC was evaluated in COPD patients three years prior to LC diagnosis. Relative telomere length measured using qPCR and serum levels of 8-OHdG were determined at the baseline in 99 COPD smokers (33 with LC and 66 age-matched COPD without LC as controls). Of these, 21 COPD with LC and 42 controls had the biomarkers measured 3 years before. Single nucleotide variants (SNVs) in TERT, RTEL, and NAF1 genes were also determined. COPD cases were evaluated, which showed greater telomere length (
    Language English
    Publishing date 2024-01-26
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2704216-9
    ISSN 2076-3921
    ISSN 2076-3921
    DOI 10.3390/antiox13020156
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Eosinophil Subtypes in Adults with Asthma and Adults with Chronic Obstructive Pulmonary Disease.

    Cabrera López, Carlos / Sánchez Santos, Alejandra / Lemes Castellano, Angelina / Cazorla Rivero, Sara / Breña Atienza, Joaquín / González Dávila, Enrique / Celli, Bartolomé / Casanova Macario, Ciro

    American journal of respiratory and critical care medicine

    2023  Volume 208, Issue 2, Page(s) 155–162

    Abstract: Rationale: ...

    Abstract Rationale:
    MeSH term(s) Humans ; Adult ; Animals ; Mice ; Eosinophils ; Leukocyte Count ; Pulmonary Disease, Chronic Obstructive/drug therapy ; Asthma ; Sialic Acid Binding Immunoglobulin-like Lectins/therapeutic use
    Chemical Substances Sialic Acid Binding Immunoglobulin-like Lectins
    Language English
    Publishing date 2023-04-18
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 1180953-x
    ISSN 1535-4970 ; 0003-0805 ; 1073-449X
    ISSN (online) 1535-4970
    ISSN 0003-0805 ; 1073-449X
    DOI 10.1164/rccm.202301-0149OC
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article: Home noninvasive ventilation in severe COPD: in whom does it work and how?

    Raveling, Tim / Vonk, Judith M / Hill, Nicholas S / Gay, Peter C / Casanova, Ciro / Clini, Enrico / Köhnlein, Thomas / Márquez-Martin, Eduardo / Schneeberger, Tessa / Murphy, Patrick B / Struik, Fransien M / Kerstjens, Huib A M / Duiverman, Marieke L / Wijkstra, Peter J

    ERJ open research

    2024  Volume 10, Issue 1

    Abstract: Background: Not all hypercapnic COPD patients benefit from home noninvasive ventilation (NIV), and mechanisms through which NIV improves clinical outcomes remain uncertain. We aimed to identify "responders" to home NIV, denoted by a beneficial effect of ...

    Abstract Background: Not all hypercapnic COPD patients benefit from home noninvasive ventilation (NIV), and mechanisms through which NIV improves clinical outcomes remain uncertain. We aimed to identify "responders" to home NIV, denoted by a beneficial effect of NIV on arterial partial pressure of carbon dioxide (
    Methods: We used individual patient data from previous published trials collated for a systematic review. Linear mixed-effect models were conducted to compare the effect of NIV on
    Findings: Data of 1142 participants from 16 studies were used. Participants treated with lower pressure support (<14
    Interpretation: With greater pressure support and better daily NIV usage, a larger improvement in
    Language English
    Publishing date 2024-02-12
    Publishing country England
    Document type Journal Article
    ZDB-ID 2827830-6
    ISSN 2312-0541
    ISSN 2312-0541
    DOI 10.1183/23120541.00600-2023
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: The 7 Cardinal Sins of COPD in Spain.

    Luis Izquierdo, José / Casanova, Ciro / Celli, Bartolomé / Santos, Salud / Sibila, Oriol / Sobradillo, Patricia / Agusti, Alvar

    Archivos de bronconeumologia

    2022  Volume 58, Issue 6, Page(s) 498–503

    Abstract: Chronic obstructive pulmonary disease (COPD) is a public health problem due to its high prevalence (11% in the adult population in Spain), increasing incidence, and great social and economic impact. Despite this, it is underdiagnosed (and, therefore, ... ...

    Abstract Chronic obstructive pulmonary disease (COPD) is a public health problem due to its high prevalence (11% in the adult population in Spain), increasing incidence, and great social and economic impact. Despite this, it is underdiagnosed (and, therefore, undertreated) at a rate of around 80%. In this paper, a group of respiratory physicians specializing in COPD discuss 7 fundamental problems ("cardinal sins") that contribute to this situation, with the explicit aim of proposing specific solutions that may help to improve this unfavorable state of affairs.
    MeSH term(s) Adult ; Humans ; Incidence ; Prevalence ; Pulmonary Disease, Chronic Obstructive/diagnosis ; Pulmonary Disease, Chronic Obstructive/epidemiology ; Pulmonary Disease, Chronic Obstructive/therapy ; Spain/epidemiology
    Language Spanish
    Publishing date 2022-01-07
    Publishing country Spain
    Document type Journal Article
    ZDB-ID 733126-5
    ISSN 1579-2129 ; 0300-2896
    ISSN (online) 1579-2129
    ISSN 0300-2896
    DOI 10.1016/j.arbres.2021.12.008
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article: Unravelling young COPD and pre-COPD in the general population.

    Cosío, Borja G / Casanova, Ciro / Soler-Cataluña, Juan José / Soriano, Joan B / García-Río, Francisco / de Lucas, Pilar / Alfageme, Inmaculada / Rodríguez González-Moro, José Miguel / Sánchez, Guadalupe / Ancochea, Julio / Miravitlles, Marc

    ERJ open research

    2023  Volume 9, Issue 1

    Abstract: Background: Chronic obstructive pulmonary disease (COPD) is commonly diagnosed when the airflow limitation is well established and symptomatic. We aimed to identify individuals at risk of developing COPD according to the concept of pre-COPD and compare ... ...

    Abstract Background: Chronic obstructive pulmonary disease (COPD) is commonly diagnosed when the airflow limitation is well established and symptomatic. We aimed to identify individuals at risk of developing COPD according to the concept of pre-COPD and compare their clinical characteristics with 1) those who have developed the disease at a young age, and 2) the overall population with and without COPD.
    Methods: The EPISCAN II study is a cross-sectional, population-based study that aims to investigate the prevalence of COPD in Spain in subjects ≥40 years of age. Pre-COPD was defined as the presence of emphysema >5% and/or bronchial thickening by computed chromatography (CT) scan and/or diffusing capacity of the lung for carbon monoxide (
    Results: Among the 1077 individuals with FEV
    Conclusions: 22.3% of the studied population was at risk of developing COPD, with similar symptomatic and structural changes to those with well-established disease without airflow obstruction. This COPD at-risk population is different from those that develop COPD at a young age.
    Language English
    Publishing date 2023-02-20
    Publishing country England
    Document type Journal Article
    ZDB-ID 2827830-6
    ISSN 2312-0541
    ISSN 2312-0541
    DOI 10.1183/23120541.00334-2022
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article: Circulating levels of mitochondrial oxidative stress-related peptides MOTS-c and Romo1 in stable COPD: A cross-sectional study.

    Amado, Carlos A / Martín-Audera, Paula / Agüero, Juan / Lavín, Bernardo A / Guerra, Armando R / Boucle, Daymara / Ferrer-Pargada, Diego / Berja, Ana / Martín, Fernando / Casanova, Ciro / García-Unzueta, Mayte

    Frontiers in medicine

    2023  Volume 10, Page(s) 1100211

    Abstract: Background: MOTS-c and Romo1 are mitochondrial peptides that are modulated by oxidative stress. No previous studies have explored circulating levels of MOTS-c in patients with chronic obstructive pulmonary disease (COPD).: Methods: We enrolled 142 ... ...

    Abstract Background: MOTS-c and Romo1 are mitochondrial peptides that are modulated by oxidative stress. No previous studies have explored circulating levels of MOTS-c in patients with chronic obstructive pulmonary disease (COPD).
    Methods: We enrolled 142 patients with stable COPD and 47 smokers with normal lung function in an observational cross-sectional study. We assessed serum levels of both MOTS-c and Romo1 and associated these findings with clinical characteristics of COPD.
    Results: Compared with smokers with normal lung function, patients with COPD had lower levels of MOTS-c (
    Conclusions: Reduced levels of circulating MOTS-c and increased levels of Romo1 were detected in patients diagnosed with COPD. Low levels of MOTS-c were associated with oxygen desaturation and poorer exercise capacity using 6 min walk test. Romo1 was associated with current smoking and baseline oxygen saturation.
    Trial registration: www.clinicaltrials.gov; No.: NCT04449419; URL: www.clinicaltrials.gov. Date of registration: June 26, 2020.
    Language English
    Publishing date 2023-02-08
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2775999-4
    ISSN 2296-858X
    ISSN 2296-858X
    DOI 10.3389/fmed.2023.1100211
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: What's New in GOLD 2017?

    Sobradillo Ecenarro, Patricia / Casanova Macario, Ciro

    Archivos de bronconeumologia

    2017  Volume 53, Issue 3, Page(s) 85–86

    Title translation ¿Qué hay de nuevo en la GOLD 2017?
    MeSH term(s) Disease Progression ; Humans ; Practice Guidelines as Topic ; Pulmonary Disease, Chronic Obstructive/diagnosis ; Pulmonary Disease, Chronic Obstructive/prevention & control ; Pulmonary Disease, Chronic Obstructive/therapy
    Language Spanish
    Publishing date 2017
    Publishing country Spain
    Document type Editorial
    ZDB-ID 733126-5
    ISSN 1579-2129 ; 0300-2896
    ISSN (online) 1579-2129
    ISSN 0300-2896
    DOI 10.1016/j.arbres.2017.02.002
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Circulating miR-206 and miR-1246 as Markers in the Early Diagnosis of Lung Cancer in Patients with Chronic Obstructive Pulmonary Disease.

    Córdoba-Lanús, Elizabeth / Domínguez de-Barros, Angélica / Oliva, Alexis / Mayato, Delia / Gonzalvo, Francisca / Remírez-Sanz, Ana / Zulueta, Javier J / Celli, Bartolomé / Casanova, Ciro

    International journal of molecular sciences

    2023  Volume 24, Issue 15

    Abstract: Lung cancer (LC) is the most common cause of cancer death, with 75% of cases being diagnosed in late stages. This study aimed to determine potential miRNAs as biomarkers for the early detection of LC in chronic obstructive pulmonary disease (COPD) cases. ...

    Abstract Lung cancer (LC) is the most common cause of cancer death, with 75% of cases being diagnosed in late stages. This study aimed to determine potential miRNAs as biomarkers for the early detection of LC in chronic obstructive pulmonary disease (COPD) cases. Ninety-nine patients were included, with registered clinical and lung function parameters followed for 6 years. miRNAs were determined in 16 serum samples from COPD patients (four with LC and four controls) by next generation sequencing (NGS) at LC diagnosis and 3 years before. The validation by qPCR was performed in 33 COPD-LC patients and 66 controls at the two time points. Over 170 miRNAs (≥10 TPM) were identified; among these, miR-224-5p, miR-206, miR-194-5p, and miR-1246 were significantly dysregulated (
    MeSH term(s) Humans ; Gene Expression Profiling ; Lung Neoplasms/diagnosis ; Lung Neoplasms/genetics ; MicroRNAs/genetics ; Pulmonary Disease, Chronic Obstructive/diagnosis ; Pulmonary Disease, Chronic Obstructive/genetics ; Early Detection of Cancer
    Chemical Substances MicroRNAs ; MIRN1246 microRNA, human ; MIRN206 microRNA, human ; MIRN224 microRNA, human
    Language English
    Publishing date 2023-08-04
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2019364-6
    ISSN 1422-0067 ; 1422-0067 ; 1661-6596
    ISSN (online) 1422-0067
    ISSN 1422-0067 ; 1661-6596
    DOI 10.3390/ijms241512437
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Dissociation between physical capacity and daily physical activity in COPD patients. A population-based approach.

    García-Río, Francisco / Miravitlles, Marc / Soriano, Joan B / Cosío, Borja G / Soler-Cataluña, Juan José / Casanova, Ciro / de Lucas, Pilar / Alfageme, Inmaculada / González-Moro, José Miguel Rodríguez / Sánchez Herrero, María Guadalupe / Ancochea, Julio

    Respiratory medicine

    2023  Volume 207, Page(s) 107115

    Abstract: Badkground: Physical capacity (PC) and daily physical activity (PA) are two crucial factors in the clinical course of COPD, although they do not always maintain a close relationship. The objectives were to evaluate the frequency of PC-PA dissociation in ...

    Abstract Badkground: Physical capacity (PC) and daily physical activity (PA) are two crucial factors in the clinical course of COPD, although they do not always maintain a close relationship. The objectives were to evaluate the frequency of PC-PA dissociation in patients with COPD and subjects without airflow limitation (AL) and to identify its risk factors.
    Methods: A sample of 319 COPD patients and 399 subjects without AL was consecutively obtained from a population-based sample of 9092 subjects evaluated in the EPISCAN II study. Baseline evaluation included clinical questionnaires, lung function testing, blood analysis and low-dose computed tomography (CT) scan with evaluation of lung density and airway wall thickness. A distance walked in 6 min > 70% predicted was considered an indicator of normal PC, while a Yale Physical Activity Survey summary index score <51 was used to identify with sedentary lifestyle.
    Results: 166 COPD patients (52.0%) reported a sedentary lifestyle with evidence of preserved PC, while this phenomenon was present in 188 (47.1%) subjects without AL. In the COPD group, symptoms of chronic bronchitis, depression and elevated hematocrit and blood eosinophil count were identified as independent risk factors for PC-PA dissociation. In turn, in the subjects without AL, the risk factors for PC-PA dissociation were low fat-free mass, obesity and anxiety, as well as reduced levels of HDL-cholesterol and the absence of osteoporosis.
    Conclusions: Almost half of COPD patients and subjects without airflow limitation with preserved PC maintain a sedentary lifestyle, with different risk factors for sedentarism between both groups.
    MeSH term(s) Humans ; Pulmonary Disease, Chronic Obstructive ; Lung ; Exercise ; Walking ; Respiratory Function Tests
    Language English
    Publishing date 2023-01-05
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 1003348-8
    ISSN 1532-3064 ; 0954-6111
    ISSN (online) 1532-3064
    ISSN 0954-6111
    DOI 10.1016/j.rmed.2023.107115
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Prevalence of reduced lung diffusing capacity and CT scan findings in smokers without airflow limitation: a population-based study.

    Garcia-Rio, Francisco / Miravitlles, Marc / Soriano, Joan B / Cosío, Borja G / Soler-Cataluña, Juan José / Casanova, Ciro / de Lucas, Pilar / Alfageme, Inmaculada / Rodríguez González-Moro, José Miguel / Sánchez Herrero, María Guadalupe / Ancochea, Julio

    BMJ open respiratory research

    2023  Volume 10, Issue 1

    Abstract: Background: Population distribution of reduced diffusing capacity of the lungs for carbon monoxide (DLCO) in smokers and main consequences are not properly recognised. The objectives of this study were to describe the prevalence of reduced DLCO in a ... ...

    Abstract Background: Population distribution of reduced diffusing capacity of the lungs for carbon monoxide (DLCO) in smokers and main consequences are not properly recognised. The objectives of this study were to describe the prevalence of reduced DLCO in a population-based sample of current and former smoker subjects without airflow limitation and to describe its morphological, functional and clinical implications.
    Methods: A sample of 405 subjects aged 40 years or older with postbronchodilator forced expiratory volume in 1 s/forced vital capacity (FVC) >0.70 was obtained from a random population-based sample of 9092 subjects evaluated in the EPISCAN II study. Baseline evaluation included clinical questionnaires, exhaled carbon monoxide (CO) measurement, spirometry, DLCO determination, 6 min walk test, routine blood analysis and low-dose CT scan with evaluation of lung density and airway wall thickness.
    Results: In never, former and current smokers, prevalence of reduced DLCO was 6.7%, 14.4% and 26.7%, respectively. Current and former smokers with reduced DLCO without airflow limitation were younger than the subjects with normal DLCO, and they had greater levels of dyspnoea and exhaled CO, greater pulmonary artery diameter and lower spirometric parameters, 6 min walk distance, daily physical activity and plasma albumin levels (all p<0.05), with no significant differences in other chronic respiratory symptoms or CT findings. FVC and exhaled CO were identified as independent risk factors for low DLCO.
    Conclusion: Reduced DLCO is a frequent disorder among smokers without airflow limitation, associated with decreased exercise capacity and with CT findings suggesting that it may be a marker of smoking-induced early vascular damage.
    Trial registration number: NCT03028207.
    MeSH term(s) Humans ; Pulmonary Disease, Chronic Obstructive ; Smokers ; Carbon Monoxide ; Prevalence ; Lung/diagnostic imaging ; Tomography, X-Ray Computed
    Chemical Substances Carbon Monoxide (7U1EE4V452)
    Language English
    Publishing date 2023-02-07
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2736454-9
    ISSN 2052-4439 ; 2052-4439
    ISSN (online) 2052-4439
    ISSN 2052-4439
    DOI 10.1136/bmjresp-2022-001468
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top